Loading clinical trials...
Loading clinical trials...
MOTHER Trial: Efficacy and Safety of Low-dose Intrathecal Morphine Following Planned Caesarean Section - a Randomised, Blinded, Clinical, Controlled, Multicentre Trial.
Conditions
Interventions
Intrathecal Morphine
Placebo (Sodium Chloride Injection, 0.9%)
Locations
8
Denmark
Aarhus University Hospital
Aarhus, Denmark
Copenhagen University Hospital - Rigshospitalet
Copenhagen, Denmark
Copenhagen University Hospital - Herlev and Gentofte, Herlev
Herlev, Denmark
Copenhagen University Hospital - North Zealand, Hillerød
Hillerød, Denmark
Copenhagen University Hospital - Amager and Hvidovre, Hvidovre
Hvidovre, Denmark
University Hospital of Southern Denmark - Lillebælt Hospital, Kolding
Kolding, Denmark
Start Date
July 15, 2025
Primary Completion Date
May 31, 2027
Completion Date
June 30, 2027
Last Updated
December 19, 2025
NCT06862609
NCT07327463
NCT07436806
NCT07442721
NCT07440940
NCT07413055
Lead Sponsor
Anne Juul Wikkelsø
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions